{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:02:05Z","timestamp":1789916525752,"version":"4.0.1"},"reference-count":24,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2005,11,30]],"date-time":"2005-11-30T00:00:00Z","timestamp":1133308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:p>The polymorphism at codon 129 (M129V) of the prion protein gene (<jats:italic>PRNP<\/jats:italic>) is a recognized genetic marker for susceptibility to Creutzfeldt\u2013Jakob disease (CJD) in the Caucasians. The distribution of this polymorphism in healthy individuals provides an important starting point for the evaluation of CJD risk in the general population. Early studies of reference population cohorts demonstrated that methionine\/valine heterozygosity was the most frequent genotype. These studies were performed in relatively small numbers of control subjects and do not correspond with the findings of more recent investigations. In this study, we present an analysis of the codon M129V distribution in 613 corneal donors, representing one of the largest control groups examined to date. Methionine homozygotes represented 48.1%, valine homozygotes 8.7% and methionine\/valine heterozygotes 43.2%. While age\u2010related difference was not significant, differentiation according to the gender showed significant difference. The observed highest proportion of methionine homozygotes and statistically significant difference between genders as well as comparison with results obtained in other countries underline the need to re\u2010evaluate the generally used reference data on M129V, including consideration of the gender, age and geographical distribution.<\/jats:p>","DOI":"10.1111\/j.1468-1331.2005.01110.x","type":"journal-article","created":{"date-parts":[[2005,11,30]],"date-time":"2005-11-30T23:51:16Z","timestamp":1133394676000},"page":"998-1001","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Creutzfeldt\u2013Jakob disease risk and<i>PRNP<\/i>codon 129 polymorphism: necessity to revalue current data"],"prefix":"10.1111","volume":"12","author":[{"given":"E.","family":"Mitrov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Jovankovi\u010dov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Slivarichov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ws\u00f3lov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,11,30]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)01342-2"},{"key":"e_1_2_6_3_1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00401-003-0700-7","article-title":"Polymorphism of the codon 129 of the prion protein (PrP) gene and neuropathology of cerebral ageing","volume":"106","author":"Berr C","year":"2003","journal-title":"Acta Neuropathol (Berl)"},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.55782\/ane-2001-1397","article-title":"Codon 129 polymorphism of the PRNP gene in normal Polish population and in Creutzfeldt\u2010Jakob disease and the search for new mutations in PRNP gene","volume":"61","author":"Bratosiewicz J","year":"2001","journal-title":"Acta Neurobiol Exp (Warsz)"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)93128-V"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.4.593"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-75-1-23"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/353801b0"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5200754"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2990.2000.00279.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)05208-8"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.12.2347"},{"key":"e_1_2_6_13_1","first-page":"285","article-title":"Prion protein genotype and pathological phenotype studies in sporadic Creutzfeldt\u2010Jakob disease","volume":"9","author":"MacDonald S","year":"1996","journal-title":"Eur J Hum Genet"},{"key":"e_1_2_6_14_1","first-page":"31","article-title":"Creutzfeldt\u2010Jakob disease with E200K mutation in Slovakia: characterization and development","volume":"46","author":"Mitrov\u00e1 E","year":"2002","journal-title":"Acta Virol"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0404.2003.00199.x"},{"key":"e_1_2_6_16_1","first-page":"1215","article-title":"Codon 129 changes in the prion protein gene in Caucasians","volume":"46","author":"Owen F","year":"1990","journal-title":"Am J Genet"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/352340a0"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/115.3.675"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001327"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00201596"},{"key":"e_1_2_6_21_1","first-page":"353","article-title":"Polymorphism at codon 129 on the prion protein gene determines cerebellar pathology in Creutzfeldt\u2010Jakob disease","volume":"15","author":"Schulz\u2010Schaefer W","year":"1996","journal-title":"Clin Neuropathol"},{"key":"e_1_2_6_22_1","volume-title":"Manual for Strengthening Diagnosis and Surveillance of Creutzfeldt\u2010Jakob Disease","author":"WHO","year":"1998"},{"key":"e_1_2_6_23_1","volume-title":"Manual for Surveillance of Human Spongiform Encephalopathies Including Variant CJD","author":"WHO","year":"2003"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0753-3322(99)80054-7"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004010050998"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1331.2005.01110.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1331.2005.01110.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T06:33:50Z","timestamp":1706769230000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1331.2005.01110.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,30]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["10.1111\/j.1468-1331.2005.01110.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1331.2005.01110.x","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,30]]},"assertion":[{"value":"2005-11-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}